Hypoxia and Hypoxia-Inducible Factors in Lymphedema.

Front Pharmacol

VA Palo Alto Health Care System, Palo Alto, CA, United States.

Published: March 2022

Lymphedema is a chronic inflammatory disorder characterized by edema, fat deposition, and fibrotic tissue remodeling. Despite significant advances in lymphatic biology research, our knowledge of lymphedema pathology is incomplete. Currently, there is no approved pharmacological therapy for this debilitating disease. Hypoxia is a recognized feature of inflammation, obesity, and fibrosis. Understanding hypoxia-regulated pathways in lymphedema may provide new insights into the pathobiology of this chronic disorder and help develop new medicinal treatments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017680PMC
http://dx.doi.org/10.3389/fphar.2022.851057DOI Listing

Publication Analysis

Top Keywords

hypoxia hypoxia-inducible
4
hypoxia-inducible factors
4
lymphedema
4
factors lymphedema
4
lymphedema lymphedema
4
lymphedema chronic
4
chronic inflammatory
4
inflammatory disorder
4
disorder characterized
4
characterized edema
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!